The objective of this study was to perform a cultural adaptation and define the validity of the Turkish version of the Intermittent Claudication Questionnaire (ICQ) in order to provide a practical instrument for the evaluation of the impact of intermittent claudication (IC) on patients' quality of life and response to therapy. A standard 'forward-backward' translation method was used to translate the questionnaire into Turkish. Reliability was assessed by internal consistency of the questionnaire reporting Cronbach's α coefficient, test-retest reliability that was assessed with the intraclass correlation between instrument scores over time and with the Spearman-Brown coefficient as a variant of split-half reliability. Validity was examined by correlation of the ICQ with the scores of the SF-36 and its eight domains. Eighty-four patients (mean age, 60.7 ± 7.3 years; male, 57%) were given the ICQ and a final completion rate of 98.8% (83 patients) was reached. The mean total ICQ score was 39.1 ± 21.8 (SD) (0-100) for the first application of the questionnaire. Thirty patients out of the eligible 83 completed the questionnaire at two time points with a 1-day interval. For the retest, the total ICQ score was 40.6 ± 26.1 (4.7-97.2). The total SF-36 score of all the study patients was 33.8 ± 20.7 (3.0-81.0). Cronbach's α was 0.95; the Spearman-Brown coefficient was 0.92; and the intraclass correlation coefficient for the two measurements was 0.91. For the total score and for the scores of domains except the emotional role domain, the correlations were high and all the correlations were statistically significant. In conclusion, the Turkish version of the ICQ, which is a disease-specific, self-administered, and practical instrument, is reliable and valid. We recommend its use to assess the effect of IC on the quality of life of patients in clinical trials and in daily clinical practice.
Introduction
Intermittent claudication (IC) is characterized by mild to severe pain and cramps in the lower limbs that are induced by exercise and relieved by rest. It is a result of the muscle ischemia during exercise due to the occlusion of the major arteries in the leg, a condition that can occur in peripheral occlusive arterial disease. 1 It has a prevalence of 0.6-10%, 2 which increases with age. Its prevalence in the general population is likely to increase dramatically over the next decades as a result of the aging population in developed and developing countries. The most important risk factor for the development of IC is cigarette smoking followed by diabetes, hypertension, hyperlipidemia, and hyperhomocysteinemia. 3 Treatment of IC involves exercise and risk factor modification with antiplatelet drug therapy.
Interventional treatment options, such as angioplasty or surgical revascularization, may be necessary for patients with ischemic rest pain, ulceration, and gangrene. 1 Although most of the patients with IC have stable disease for many years, progression to severe limbthreatening ischemia with rest pain and tissue loss is possible, with only 1-7% risk of amputation at 5-10 years. 4 But patients with IC have a significantly increased mortality rate, which is 12% a year. 5 More significantly, IC has a negative impact on various aspects of quality of life (QoL) [6] [7] [8] [9] [10] as a result of functional disability causing deterioration in the personal, social, or occupational life of patients.
The response to treatment is usually evaluated with walking distance 11 for exercise therapy or with duplex scanning 12 or ankle pressures 13 for interventional therapies. Since the response to each treatment is evaluated with a different method, there is a need for methods to objectively evaluate a patient's individual perspective of his or her disease-related complaints. 14 Recently, studies focused on the assessment of QoL in patients with IC for the evaluation of the impact of IC on patients' lives and their responses to therapy. 15 In the TransAtlantic Inter-Society Consensus (TASC) 2000 report, it was stated that the primary end-point should be QoL in clinical practice and research studies, providing an accurate assessment of QoL. 16 The Sickness Impact Profile (SIP), 8 Medical Outcomes Study 36-item short form health survey (SF-36), 7, 9 Nottingham Health Profile (NHP), 10 McMaster Health Index Questionnaire, and the Squibb Quality of Life General Health Index 17 were the generic questionnaires that have been used to assess QoL in patients with IC. Although these generic questionnaires may be able to detect a poorer QoL in patients with IC, they may not detect improvements in IC after treatment. Furthermore, since they are designed for use also in other conditions, they may not focus on IC.
There is a limited number of instruments specific to IC for the assessment of health-related QoL. The Walking Impairment Questionnaire (WIQ), 18 an objective measure of a patient's walking ability, is a function-specific measure of outcome that is interviewer-administered and based around patient estimates of claudication symptom severity and physical ability. Thus, it relies on the accuracy of patient estimation.
The Claudication Scale (CLAU-S) 19 ,20 is a diseasespecific questionnaire with validated English, French, German and Flemish versions. But the original version of CLAU-S is considerably long and not practical.
The Intermittent Claudication Questionnaire (ICQ) is a disease-specific instrument for the assessment of health-related QoL in patients with IC. It is a self-administered questionnaire with a 5-point adjectival scale with 16 items scoring between 0 and 100 (0 = worst, 100 = best). It was developed and validated in English in the study by Chong et al., 21 where 121 patients completed the ICQ (mean time, 3.7 min). Test-retest intraclass correlation (ICC) and Cronbach's α were 0.95 and 0.94, respectively. 21 The ICQ correlated with seven out of eight subscales of the SF-36 (r = 0.33-0.68). The ICQ demonstrated the largest standardized response mean in relation to health transition compared with the other instruments. Therefore, ICQ is a condition-specific instrument that was found to be one of the most reliable practical, valid, and responsive measurements of patients' health-related QoL in IC.
In order to provide a practical instrument for the evaluation of the impact of IC on patients' QoL and response to therapy in daily clinical practice and in clinical studies in Turkey, we translated the ICQ into Turkish and studied its validity. This paper is written to illustrate an approach to the cultural adaptation and validation, with a focus on the Turkish model.
Materials and methods

Study patients
Peripheral arterial disease was defined by a resting ankle-brachial pressure index (ABI) ≤ 0.90 or a positive vascular treadmill test (VTT) or documented disease. To calculate the ABI, systolic pressures of brachial arteries, dorsalis pedis, and posterior tibial arteries were measured bilaterally after 5 minutes of rest in a supine position using a handheld vascular Doppler and aneroid pressure equipment. Four-cuff sizes were used (small size adult, median size adult, large size adult and thigh) based on right arm circumference at the middle position between the acromiom and olecranium. ABI was calculated for each lower limb using the highest arm systolic pressure as the denominator, and the highest ankle systolic pressure as the numerator. A vascular treadmill test was performed only for ABI threshold values (0.91-0.94). An incremental protocol was used for VTT on the treadmill at 3 km/h: inclination from 0% to 15%, with a 5% increment every 3 minutes. Pressures were measured with vascular Doppler in the supine position at rest and after exercise. The test was considered positive for the diagnosis of PAD whenever the ankle systolic pressure decrease measured at 1 minute after exercise was higher than or equal to 20% as compared to baseline, with baseline recovery time over 3 minutes. 22 Patients with an ABI > 1.40 (non-compressible arteries), limitations or contra-indications to VTT, critical limb ischemia (rest pain or tissue loss), back pain, hip or knee arthritis, limiting cardiorespiratory disease, previ-ous stroke and hemiparesis, neurological muscle weakness, drug or alcohol dependency, and chronic pain conditions other than leg pains from IC (e.g. diabetic neuropathy) were excluded from the study.
Demographic variables of the patients are shown in Table 1 . The study protocol was approved by the institutional review board (Ethical Committee) and was consistent with the principles of the Declaration of Helsinki. Written informed consent was obtained from all study participants.
Translation and cultural adaptation of the questionnaire The English version of the ICQ was obtained from the authors of the original validation study. 21 A standard 'forward-backward' translation method was used to translate the questionnaire into Turkish. Forward translation was performed by experienced translators. Several versions of translations were compared in a consensus meeting and a final form was devised. This form was further back translated into English by an independent translator who is a native English speaker. A team of clinicians and translators analyzed the differences with the original version and the final version of the questionnaire was developed. For cultural adaptation, a debriefing method was used and the final questionnaire was administered to a group of 30 patients two times with a 1-day interval in order to establish how well the questionnaire was being understood by the Turkish people. According to the feedback from these patients, the following changes were applied in the questionnaire to obtain cultural adaptation: wording was changed in some questions to increase understanding; and walking distance measures were converted into the metric system. Afterwards, the number of patients was completed at 84 and all patients were administered the final ICQ and a Turkish version of the SF-36 23 for comparison.
Reliability testing
To test the reliability, the internal consistency of the questionnaire was assessed by Cronbach's α coefficient, which measures the average level of correla-tion between items within a scale and ranges from 0 to 1; α equal to or greater than 0.70 was considered satisfactory.
Test-retest reliability was assessed with the ICC between instrument scores over time and with the Spearman-Brown coefficient as a variant of splithalf reliability. Individual items with high floor and ceiling effects were investigated. Principal component analysis (PCA) was used to identify separate dimensions of health within the instrument. Items with poor component loadings and with low levels of item-total correlation were identified. The itemtotal correlation with a coefficient higher than 0.6 was also investigated.
Validity testing
The Turkish version of the instrument was tested for construct validity by correlating scores of the ICQ with the scores of the SF-36 and its eight domains. 24 The SF-36 is a generic self-completed multidimensional questionnaire measuring health-related QoL in eight domains: physical functioning, social functioning, physical role, emotional role, pain, vitality, mental health, and general health perception. The Statistical Package for the Social Sciences (SPSS) software (SPSS v 9.0, SPSS Inc, Chicago, IL, USA) was used for the analysis.
Results
Eighty-four patients (mean age, 60.7 ± 7.3 years; male, 57%) were given the ICQ. Thirteen patients did not respond to at least one question, 12 of whom were within acceptable limits (1-8 missing responses). One patient with 11 missing responses was excluded from the study, and with 83 eligible patients a final completion rate of 98.8% was reached. The ICQ is coded with summing up five-or six-point adjectival scales that are equally weighted and transforming to a 0-100 scale (0 = worst, 100 = best possible health state). The mean total ICQ score was 39.1 ± 21.8 (SD) (0-100) for the first application of the questionnaire. Thirty patients out of the eligible 83 completed the questionnaire at two time points with a 1-day interval. For the retest, the total ICQ score was 40.6 ± 26.1 (4.7-97.2). The total SF-36 score of all study patients was 33.8 ± 20.7 (3.0-81.0).
Reliability testing
The 16-item questionnaire had a Cronbach's α of 0.95. Test-retest reliability as assessed by the Spearman-Brown coefficient was 0.92. The intraclass correlation coefficient for the two measurements was 0.91. The floor and ceiling effects were limited. The largest ceiling effect was observed for question 8 (Q8) at 36.7%, while the largest floor effects were observed for Q12 at 48%, for Q11 at 48.6%, and for Q10 at 53.3%. The PCA results of the Turkish version led to a solution with two components, which explained 57.0% and 8.1% of the variation. Sixteen questions had a more than 0.64 loading on the first component ( Table 2) . Item-total correlations ranged from 0.59 to 0.85 ( Table 2 ). The absolute inter-item correlations (IIC) were lower than 0.6 in 87.5% of the cases.
Validity testing
The Spearman correlation coefficient values between the ICQ and the eight domains and the total score of SF-36 are given in Table 3 . For the total score and for the scores of several domains except for emotional role domain, the correlations were high and all the correlations were statistically significant.
Discussion
Peripheral arterial disease is a condition with increasing prevalence. It affects the health-related QoL of patients negatively. Muller-Buhl et al. have shown that the correlations between functional disability and peripheral Doppler pressure and angiographic disease severity were weak and QoL measures were better indicators of functional disability. 25 In particular, patient self-reported QoL scales are thought to be more successful for evaluating the functional status of patients. The effects of IC on patients' QoL would be best described by patients. 26 ICQ is a disease-specific instrument that was found to be a practical, reliable, valid, and responsive measure of patients' health-related QoL in IC. 21 In this study, we translated the ICQ into Turkish and performed a cultural adaptation. We found that the Turkish version had internal consistency and test-retest reliability values that exceed standards in the literature 27 and is valid to use for the evaluation of the impact of IC on patients' QoL and for the assessment of response to therapy in daily clinical practice and in clinical studies.
We calculated the Cronbach α of the Turkish ICQ as 0.95, which is very close to the Cronbach α value of 0.94 in the validation study of the original English questionnaire. 21 This coefficient is sufficient both for use in clinical studies and for the assessment of individual patients in daily clinical practice. It has been reported that for the use of an instrument for groups of patients, a Cronbach α of at least 0.70 is required, and for decisions about individual patients a Cronbach α of 0.95 is necessary. 28 For the assessment of construct validity, we calculated Spearman's correlation coefficient and for test-retest reliability we calculated the intraclass correlation coefficient for the two measurements with a 1-day interval. Both coefficients were very high (0.92 and 0.91, respectively), showing that the ICQ was stable over time in our study population. Floor and ceiling effects were within acceptable limits in our study. The largest ceiling effect was observed for question 8 (Q8) for 36.7% of patients, while the largest floor effects were observed for Q12 for 48%, for Q11 for 48.6%, and for Q10 for 53.3% of patients. The ceiling effect occurs when test items are not challenging enough for patients. On the other hand, the floor effect is when an item cannot take a value lower than some particular number. The ceiling effect becomes a measurement problem when you are trying to identify changesthe person may continue to improve but the test does not capture that improvement. In case of the floor effect, clinical decline may not register as a change in score, even if there is worsening of the condition. In contrast to the English ICQ version, questions 10, 11 and 12 appraise a patient's mood and fears. The difference between the two versions may be due to cultural circumstances.
The result of PCA showed that ICQ had two components: the first one explained the large level of variation (57.0% and 8.1%, respectively), and all items on the questionnaire had more than 0.64 loading on the first component. These findings indicate that the instrument is measuring a single health dimension. Similarly, in the validation study of the original English ICQ version, the large level of variation was explained by the first component and all items had loadings of more than 0.65 on the first component. 21 This is important in terms of practical use of the instrument. Other claudication instruments such as the WIQ 18 and CLAU-S 19, 20 have several dimensions, which complicates their use.
High item-total correlations (from 0.59 to 0.85) in our study show consistency between total score of the instrument and each item; the low level of IIC for most of the cases show that each item measures different dimensions of QoL. These findings were in line with the findings of the original validation study of the instrument. 21 We found that the Turkish version of the ICQ is highly correlated with most of the domains and the total SF-36 score, as in the original validation study. 21 This shows that the Turkish ICQ successfully reflects the impact of IC on a variety of aspects of patients' QoL.
In conclusion, the Turkish version of the ICQ, which is a disease-specific, self-administered, and practical instrument, is reliable and valid. We recommend its use to assess the effect of IC on the QoL of patients in clinical trials and in daily clinical practice.
